Pharming's Marketing Authorization Application for Rhucin -- RHC1INH -- Accepted for Review by EMEA
17 août 2006 12h58 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 17, 2006 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming") (Euronext:PHARM) (PHARM.AS) announced today that its Marketing Authorization Application (MAA) for...
Pharming Presents rhC1INH Update at International Meetings
17 nov. 2005 02h13 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 17, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company presented clinical...
Pharming Candidate for Amsterdam Midkap Index on Euronext
09 nov. 2005 02h18 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 09, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has been selected by Euronext...
Pharming Announces Results for First Nine Months 2005
03 nov. 2005 01h24 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 3, 2005 (PRIMEZONE) -- Highlights: upcoming product filings, licensing progress and pipeline expansion. Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM)...
Pharming Appoints New Head of Finance and Administration
24 oct. 2005 01h09 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 24, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has appointed Mr. Wim J. E....
Pharming Presents Human Lactoferrin Results at International Conference
19 oct. 2005 08h07 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 19, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today results from three studies which...
Pharming Expands Clinical Development of Recombinant Human C1 Inhibitor for new Indications
29 sept. 2005 01h12 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Sept. 29, 2005 (PRIMEZONE) -- Biotech companyPharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today that it will commence clinical...
Pharming to Present at UBS Global Life Sciences Conference
20 sept. 2005 01h38 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Sept. 20, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company will present at the...
Pharming's Recombinant Human Fibrinogen Selected for U.S. Army Project
31 août 2005 02h07 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 31, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today that its recombinant human fibrinogen...
Pharming Announces First Half 2005 Results
19 août 2005 01h48 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 19, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) (Other OTC:PHGUF) announced today its results for the...